Celiac disease and type 1 diabetes: What’s the connection?
What is the link between celiac disease and type 1 diabetes? Learn what celiac disease is, how it is treated,…
Medical Affairs team kicks off international islet cell therapy workshops at Breakthrough T1D HQ
Breakthrough T1D's Medical Affairs team hosted experts in islet transplantation to discuss a clinical roadmap for manufactured cell therapies.
New Breakthrough T1D publications highlight unmet needs and demographics of the T1D population
Breakthrough T1D recently published two peer-reviewed journal articles. One detailed burdensome unmet needs in the T1D community and identified key…
Menstrual cycles, hormones, and T1D: What women need to know
Menstrual cycles and type 1 diabetes (T1D) have a lot in common: they can be unpredictable, inconsistent from person to…
Treating and preventing eye disease with type 1 diabetes
Diabetic eye disease is a troubling reality for many people living with type 1 diabetes, but research is helping reduce…
Balancing mental health and type 1 diabetes
Taking care of your mental health with type 1 diabetes is just as important as managing your blood sugar and…
Cell therapies in clinical trials: Moving the needle forward
Breakthrough T1D believes that novel cell therapies in the clinical pipeline will transform T1D management, and Project ACT is how…
Could drugs like Ozempic also benefit people with type 1 diabetes?
Learn more about GLP-1 therapies and SGLT inhibitors, and how drugs like Ozempic may one day be able to help…
From unexpected diagnosis to DIAGNODE-3 participant
Katie Howell was diagnosed with type 1 diabetes last year at age 25. Now, she's the first DIAGNODE-3 trial participant…
ATTD 2025: Closing the loop to cures
At ATTD 2025, Breakthrough T1D led sessions showcasing advancements in T1D cell therapies, early detection, and technology to improve lives.
